- Current Two EGFR Mutations in Lung Adenocarcinoma - Case Report2015 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Acquired resistance of pulmonary adenocarcinoma to initially successful targeted therapy due to EGFR mutation T790M2007 | Central Library of Charles University
- Lung adenocarcinoma with a rare EGFR mutation and infrequent resistance to treatment2022 | Central Library of Charles University, Faculty of Medicine in Pilsen
- LUX-LUNG 7 - new look at the first line treatment for patients with frequent EGFR mutations?2016 | Faculty of Medicine in Pilsen
- Long-term surviving patient with EGFR mutation - deletion on exon 79 and acquired resistant mutation T790 - case report2020 | Faculty of Medicine in Pilsen
- Patient with three EGFR mutations - gradual development of resistance to previous targeted treatment2018 | Faculty of Science, Faculty of Medicine in Pilsen
- Effect of clinical parameters on second- and third-line erlotinib treatment of EGFR wild type patients with advanced NSCLC2019 | Central Library of Charles University, First Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Detection of EGFR Mutations in Circulating Tumor DNA (ctDNA) Retrieved from Plasma - Interlaboratory Quality Assessment in the Czech Republic2018 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, First Faculty of Medicine, Second Faculty of Medicine
- Modern diagnosis of lung cancer - a task for close multidisciplinary cooperation2011 | Faculty of Medicine in Hradec Králové
- Interdisciplinary consensus for predictive testing of activation mutations of the epidermal growth factor receptor (EGFR) in non-small cell lung cancer2011 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, First Faculty of Medicine
- Results of the evaluation of osimertinib in previously non-treated patients with EGFR-mutated advanced NSCLC: FLAURA study2018 | First Faculty of Medicine
- Interdisciplinary consensus for predictive investigations in non-small cell lung cancer (NSCLC) - update 20122012 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, First Faculty of Medicine, Faculty of Medicine in Pilsen
- First experiences with detecting ALK (anaplastic lymphoma kinase) gene rearrangement and administration of crizotinib in selected patients with non-small cell lung cancer (NSCLC)2012 | Faculty of Medicine in Pilsen
- EGFR mutations in patients with advanced NSCLC2012 | Faculty of Medicine in Pilsen
- Ground-breaking ADAURA trial - osimertinib as adjuvant therapy of EGFR-mutated NSCLC2022 | First Faculty of Medicine
- Options for testing DNA mutations and DNA methylation assays of circulating cell-free DNA isolated from peripheral blood of NSCLC patients2012 | Publication without faculty affiliation
- Tagrisso TM (Osimertinib, AZD929I)2016 | Faculty of Medicine in Pilsen
- Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop2010 | First Faculty of Medicine
- Afatinib - non-small cell lung cancer in the second generation targeted therapy2014 | Publication without faculty affiliation
- Current status and prospects of targeted therapies non-small cell lung cancer2016 | Faculty of Medicine in Pilsen
- A novel high-resolution chipCE assay for rapid detection of EGFR gene mutations and amplifications in lung cancer therapy by a combination of fragment analysis, denaturing CE and MLPA2010 | Faculty of Science
- Targeted therapy of non-small cell lung cancer2021 | Faculty of Medicine in Pilsen
- Systemic therapy of lung adenocarcinoma2016 | Faculty of Medicine in Pilsen
- Erlotinib in Treatment of NSCLC (Focusing on Patients without EGFR Mutation and on Combination of Erlotinib with Bevacizumab)2017 | Faculty of Medicine in Pilsen
- Targeted treatment of NSCLC with kinase inhibitors - afatinib and nintedanib in clinical pracitce2017 | Faculty of Medicine in Pilsen
- Diagnosing lung cancer in pulmonology centers2018 | First Faculty of Medicine, Second Faculty of Medicine
- Identification of an optimal algorithm for effective diagnostics of non-small cell lung cancer with ALK gene rearrangement - implementation of the method and practical experiences with routine diagnostics2017 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine